Herceptin
Medical trial reveals Herceptin survival rate
Women taking the breast cancer drug Herceptin have similar survival rates regardless of whether they take it for nine weeks or a year, a study has revealed.
Herceptin study: 'Shorter therapy just as good'
A new study has revealed that women taking the expensive anti cancer drug, Herceptin, have similar survival rates regardless of whether they take it for nine weeks or a year. In 2007 Pharmac was… Audio
Herceptin trial shows 9 weeks as good as a year
A medical trial has shown Pharmac was right when it made a controversial decision to fund the breast cancer drug Herceptin for just nine weeks of treatment. The former National government overturned… Audio
Herceptin study involving NZ women reveals survival rates
Survival rates for women taking Herceptin for breast cancer are similar whether they take a short or long course of treatment on the drug. That's the result of a long-awaited study involving New… Audio
The media clamour for funding cancer drugs
The government is under pressure to pay for another costly cancer 'wonder drug'. It's not the first time the media have weighed in on how the nation's pharmaceutical budget should be spent, egged on… Audio
Long-time medical director of Pharmac set to stand down
An outgoing leader at Pharmac says funding of the breast cancer drug Herceptin was the toughest decision he was involved in. Audio
Cancer lobby raises ethical questions over Herceptin study
A breast cancer lobby group is seeking to end New Zealand's participation in a key trial involving the breast cancer drug Herceptin. Audio
Funding for new breast cancer drug disappoints
Pharmac has decided to fund a new treatment for those with aggressive breast cancer, as an alternative to Herceptin. Audio
Breast cancer patients
Cancer specialists are contacting breast cancer patients who may wish to take up the new offer of longer treatment with the drug Herceptin. Audio
Government side step Pharmac over Herceptin
The Government's decision to side step Pharmac and fund the breast cancer drug Herceptin is being criticised. Audio
Government announces 12-month Herceptin funding
The Government has announced it will fund a full 12 months of the breast cancer drug Herceptin. Audio
Herceptin (Part 2)
Breast cancer specialist, Dr Vernon Harvey spoke to Geoff about why he supports the drug being offered on a 12-month basis. Audio
Herceptin
Government, no funding increases for the breast cancer drug. National says it would fund 12-month treatments. Audio
The Herceptin Debate
The drug-buying agency Pharmac has once again said no to funding the 12 month course of the breast cancer drug, Herceptin. Audio
Cancer Drug Decision Due
Pharmac is to announce on today whether it will fund longer courses of Herceptin for women with early aggressive breast cancer Audio
Herceptin Data
Unpublished data shows the breast cancer drug Herceptin may be a third less effective if it's given after chemotherapy. Audio
Pharmac to Fully Fund Herceptin
At least one lawyer is warning supporters of the drug for women with early breast cancer, not to get their hopes up. Audio
Herceptin Ultimatum
Campaigners for the breast-cancer drug, Herceptin, have issued an ultimatum to the government in election year. Audio
Pharmac Review
The drug-buying agency has been completing it defence in a judicial review case brought by eight breast cancer patients. Audio
Herceptin Court Case
The drug agency Pharmac says it did everything right in deciding on a contentious funding plan for the breast cancer drug. Audio